AU4196099A - Long-circulating liposomal compositions - Google Patents

Long-circulating liposomal compositions

Info

Publication number
AU4196099A
AU4196099A AU41960/99A AU4196099A AU4196099A AU 4196099 A AU4196099 A AU 4196099A AU 41960/99 A AU41960/99 A AU 41960/99A AU 4196099 A AU4196099 A AU 4196099A AU 4196099 A AU4196099 A AU 4196099A
Authority
AU
Australia
Prior art keywords
long
liposomal compositions
circulating
circulating liposomal
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU41960/99A
Inventor
Gregory E Hardee
Christopher Leamon
Rahul Mehta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ionis Pharmaceuticals Inc
Original Assignee
Isis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Pharmaceuticals Inc filed Critical Isis Pharmaceuticals Inc
Publication of AU4196099A publication Critical patent/AU4196099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
AU41960/99A 1998-05-21 1999-05-20 Long-circulating liposomal compositions Abandoned AU4196099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8236598A 1998-05-21 1998-05-21
US09082365 1998-05-21
PCT/US1999/011267 WO1999059547A1 (en) 1998-05-21 1999-05-20 Long-circulating liposomal compositions

Publications (1)

Publication Number Publication Date
AU4196099A true AU4196099A (en) 1999-12-06

Family

ID=22170750

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41960/99A Abandoned AU4196099A (en) 1998-05-21 1999-05-20 Long-circulating liposomal compositions

Country Status (2)

Country Link
AU (1) AU4196099A (en)
WO (1) WO1999059547A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6228642B1 (en) * 1998-10-05 2001-05-08 Isis Pharmaceuticals, Inc. Antisense oligonucleotide modulation of tumor necrosis factor-(α) (TNF-α) expression
US8518437B2 (en) 2001-11-13 2013-08-27 Celator Pharmaceuticals, Inc. Lipid carrier compositions with enhanced blood stability
WO2004082688A1 (en) * 2003-03-20 2004-09-30 Vasogen Ireland Limited Phosphatidylglycerol (pg) receptor agonists and antagonists
US8017159B2 (en) * 2005-11-16 2011-09-13 Idexx Laboratories, Inc. Phospholipid gel compositions for delivery of aptamers and methods of treating conditions using same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843473A (en) * 1989-10-20 1998-12-01 Sequus Pharmaceuticals, Inc. Method of treatment of infected tissues
US5820848A (en) * 1990-01-12 1998-10-13 The Liposome Company, Inc. Methods of preparing interdigitation-fusion liposomes and gels which encapsulate a bioactive agent
GB9208339D0 (en) * 1992-04-15 1992-06-03 Unilever Plc Treatment composition

Also Published As

Publication number Publication date
WO1999059547A1 (en) 1999-11-25

Similar Documents

Publication Publication Date Title
AU1522300A (en) Bleach compositions
AU4911199A (en) Cosmetic composition
AU5918999A (en) Modular rotor
AU2349399A (en) R-lansoprazole compositions and methods
AU5157898A (en) Hnf3delta compositions
AU5335798A (en) Stomatic composition
AU8747498A (en) Food-preservative composition
AU5965399A (en) Pharmaceutically active composition
AU5575398A (en) Hairdye compositions
AUPP461398A0 (en) Cementitious composition
AU4090299A (en) Liposomal delivery complex
AU6256298A (en) Cosmetic compositions
AU2656799A (en) Metal-thiols as imminomodulating agents
AU8121998A (en) Composition
AU3000599A (en) Moisturizing compositions
AU1573600A (en) Microemulsion compositions
AU2899899A (en) Cosmetic compositions
AUPP332898A0 (en) Pharmaceutical composition
AU4196099A (en) Long-circulating liposomal compositions
AU5378599A (en) Oral formulation
AU1707599A (en) Retinoid-glitazone combinations
AU1098499A (en) Emulsifier-lipid composition
AU6217199A (en) Compositions
AU4910199A (en) Oral composition
AU5757799A (en) Weed-controlling agents

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase